2021 Q4 Form 10-K Financial Statement
#000143774922007387 Filed on March 28, 2022
Income Statement
Concept | 2021 Q4 | 2021 | 2020 Q4 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.609M | $3.185M | $966.7K |
YoY Change | 66.41% | 228.77% | |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $140.0K | $1.009M | |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $1.609M | $3.185M | $966.7K |
YoY Change | 66.41% | 228.77% | |
Operating Profit | $2.910M | ||
YoY Change | |||
Interest Expense | $1.755M | $6.132M | -$2.056M |
YoY Change | -185.36% | -398.27% | |
% of Operating Profit | 210.74% | ||
Other Income/Expense, Net | -$1.410M | ||
YoY Change | |||
Pretax Income | $146.3K | $2.947M | -$3.023M |
YoY Change | -104.84% | -197.43% | |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | 0.0% | 0.0% | |
Net Earnings | $146.3K | $2.947M | -$442.4K |
YoY Change | -133.07% | -197.43% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | ||
Diluted Earnings Per Share | $8.607K | $173.4K | -$177.8K |
COMMON SHARES | |||
Basic Shares Outstanding | 0.000 | ||
Diluted Shares Outstanding | 0.000 |
Balance Sheet
Concept | 2021 Q4 | 2021 | 2020 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $138.9M | $138.9M | $139.8M |
YoY Change | -0.69% | -0.69% | |
Cash & Equivalents | $203.9M | $72.00K | |
Short-Term Investments | $138.8M | $138.8M | $138.7M |
Other Short-Term Assets | $239.7K | $239.7K | $403.2K |
YoY Change | -40.56% | -40.56% | |
Inventory | |||
Prepaid Expenses | $239.7K | $403.2K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $139.1M | $139.1M | $140.2M |
YoY Change | -0.8% | -0.8% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $71.78M | ||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $164.8M | $0.00 | -$4.00 |
YoY Change | -4119314850.0% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $139.1M | $139.1M | $140.2M |
Total Long-Term Assets | $164.8M | $0.00 | -$4.00 |
Total Assets | $303.9M | $139.1M | $140.2M |
YoY Change | 116.69% | -0.8% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.175M | $1.175M | |
YoY Change | 663.32% | ||
Accrued Expenses | $4.560M | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.000M | $1.000M | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.935M | $6.935M | $4.914M |
YoY Change | 41.13% | 41.13% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $11.91M | $11.91M | $18.00M |
YoY Change | -33.85% | -33.85% | |
Total Long-Term Liabilities | $11.91M | $11.91M | $18.00M |
YoY Change | -33.85% | -33.85% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.935M | $6.935M | $4.914M |
Total Long-Term Liabilities | $11.91M | $11.91M | $18.00M |
Total Liabilities | $232.9M | $18.84M | $22.92M |
YoY Change | 916.38% | -17.78% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $0.00 | -$21.38M | |
YoY Change | -100.0% | ||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$18.44M | $120.3M | -$21.38M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $303.9M | $139.1M | $140.2M |
YoY Change | 116.69% | -0.8% |
Cashflow Statement
Concept | 2021 Q4 | 2021 | 2020 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $146.3K | $2.947M | -$442.4K |
YoY Change | -133.07% | -197.43% | |
Depreciation, Depletion And Amortization | $140.0K | $1.009M | |
YoY Change | |||
Cash From Operating Activities | -$736.5K | -$1.965M | -$706.0K |
YoY Change | 4.32% | 177.5% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $10.36M | $162.0K | |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$13.88K | -$42.28K | -$138.7M |
YoY Change | -99.99% | -99.97% | |
Cash From Investing Activities | -$13.88K | -$42.28K | -$138.7M |
YoY Change | -99.99% | -99.97% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | $1.000M | 140.5M |
YoY Change | -100.0% | -99.29% | |
NET CHANGE | |||
Cash From Operating Activities | -736.5K | -$1.965M | -706.0K |
Cash From Investing Activities | -13.88K | -$42.28K | -138.7M |
Cash From Financing Activities | 0.000 | $1.000M | 140.5M |
Net Change In Cash | -750.4K | -$1.008M | 1.095M |
YoY Change | -168.55% | -189.79% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$736.5K | -$1.965M | -$706.0K |
Capital Expenditures | $10.36M | $162.0K | |
Free Cash Flow | -$11.10M | -$2.127M | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Assets
Assets
|
139114407 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
140241606 | USD |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1174980 | USD |
CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
153928 | USD |
CY2021 | dei |
Auditor Location
AuditorLocation
|
Omaha, NE | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2021Q4 | skyh |
Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
|
1 | pure |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Cash
Cash
|
114626 | USD |
CY2020Q4 | us-gaap |
Cash
Cash
|
1122194 | USD |
CY2021Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
138760121 | USD |
CY2020Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
138716226 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
239660 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
403186 | USD |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1000000 | USD |
CY2020Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | USD |
CY2021Q4 | skyh |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
4759615 | USD |
skyh |
Ajustments To Additional Paid In Capital Reclassification Of Warrants To Liabilities
AjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsToLiabilities
|
-15933513 | USD | |
skyh |
Reclassification To Temporary Equity Value
ReclassificationToTemporaryEquityValue
|
138708760 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3024804 | USD | |
CY2020Q4 | skyh |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
4759615 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6934595 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4913543 | USD |
CY2021Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
11908671 | USD |
CY2020Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
18003841 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
18843266 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
22917384 | USD |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
0 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
0 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-18437959 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-21384878 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18437619 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21384538 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
139114407 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
140241606 | USD |
CY2021 | us-gaap |
Professional Fees
ProfessionalFees
|
2345854 | USD |
us-gaap |
Professional Fees
ProfessionalFees
|
656563 | USD | |
CY2021 | us-gaap |
Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
|
200000 | USD |
us-gaap |
Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
|
70542 | USD | |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
639439 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
241749 | USD | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-6095170 | USD |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2070328 | USD | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
2909877 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3039182 | USD | |
CY2021 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
35423 | USD |
us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
0 | USD | |
CY2021 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
0 | USD |
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
12297 | USD | |
CY2021 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
1619 | USD |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
2081 | USD | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
2946919 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3024804 | USD | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2946919 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3024804 | USD | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
7451220 | USD | |
skyh |
Overallotment Reduction Value
OverallotmentReductionValue
|
-0 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
7719779 | USD | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21384538 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2946919 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18437619 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2946919 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3024804 | USD | |
CY2021 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
1619 | USD |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
2081 | USD | |
CY2021 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-0 | USD |
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
12297 | USD | |
CY2021 | skyh |
Issuance Costs Warrants
IssuanceCostsWarrants
|
0 | USD |
skyh |
Issuance Costs Warrants
IssuanceCostsWarrants
|
509899 | USD | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-6095170 | USD |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2070328 | USD | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-163526 | USD |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
403186 | USD | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1021052 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
153928 | USD | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1965292 | USD |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-708213 | USD | |
CY2021 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
1179227029 | USD |
us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
266000000 | USD | |
CY2021 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
1179269305 | USD |
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
404701848 | USD | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-42276 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-138701848 | USD | |
CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
7719779 | USD | |
CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1000000 | USD |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD | |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
-0 | USD |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3201504 | USD | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1000000 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
140532255 | USD | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1007568 | USD |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1122194 | USD | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1122194 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
0 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
114626 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1122194 | USD |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD | |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
CY2020Q4 | skyh |
Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
|
10.20 | |
CY2021Q4 | skyh |
Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
|
0.80 | pure |
CY2021Q4 | skyh |
Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
|
0.50 | pure |
CY2021 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <em style="font: inherit;"> may </em>exceed the Federal Depository Insurance Coverage of <em style="font: inherit;">$250,000.</em> At <em style="font: inherit;"> December 31, 2021, </em>the Company has <em style="font: inherit;">not</em> experienced losses on these accounts and management believes the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> | |
CY2021Q4 | skyh |
Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
|
2500000 | USD |
CY2020Q4 | skyh |
Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
|
0 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
992575 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
126379 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-767176 | USD |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-93745 | USD |
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-225399 | USD |
CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-32634 | USD |
CY2021 | skyh |
Income Tax Expense Benefit Before Allowance
IncomeTaxExpenseBenefitBeforeAllowance
|
-992575 | USD |
CY2020 | skyh |
Income Tax Expense Benefit Before Allowance
IncomeTaxExpenseBenefitBeforeAllowance
|
-126379 | USD |
CY2021 | skyh |
Income Tax Expense Benefit Valuation Allowance
IncomeTaxExpenseBenefitValuationAllowance
|
-992575 | USD |
CY2020 | skyh |
Income Tax Expense Benefit Valuation Allowance
IncomeTaxExpenseBenefitValuationAllowance
|
-126379 | USD |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2021Q4 | skyh |
Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
|
0.35 | |
CY2021Q4 | skyh |
Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
|
4759615 | USD |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
618853 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-93745 | USD |
CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
182709 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-32634 | USD |
CY2021 | skyh |
Income Tax Rate Reconciliation Unrealized Gain On Warrant
IncomeTaxRateReconciliationUnrealizedGainOnWarrant
|
-1657887 | USD |
CY2020 | skyh |
Income Tax Rate Reconciliation Unrealized Gain On Warrant
IncomeTaxRateReconciliationUnrealizedGainOnWarrant
|
0 | USD |
CY2021 | skyh |
Income Tax Rate Reconciliation Unrealized Gain On Securities
IncomeTaxRateReconciliationUnrealizedGainOnSecurities
|
-440 | USD |
CY2020 | skyh |
Income Tax Rate Reconciliation Unrealized Gain On Securities
IncomeTaxRateReconciliationUnrealizedGainOnSecurities
|
0 | USD |
CY2021 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-9431 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
0 | USD |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
866196 | USD |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
126379 | USD |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
455199 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
126379 | USD |
CY2021Q4 | skyh |
Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
|
537376 | USD |
CY2021Q4 | skyh |
Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
|
0.20 | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-6095170 | USD |